7Baggers
 Published on: 2025-11-15 18:34:42  newser.com Sun, 16 Nov 2025 00:34:42 GMT
 published on: 2025-11-14 04:07:44  newser.com Fri, 14 Nov 2025 10:07:44 GMT
 Published on: 2025-11-14 00:49:03  newser.com Fri, 14 Nov 2025 06:49:03 GMT
 published on: 2025-11-10 00:27:08  newser.com Mon, 10 Nov 2025 06:27:08 GMT
 Foghorn Therapeutics Unveils Strategic Advancements with Lilly  TipRanks Fri, 07 Nov 2025 22:01:11 GMT
 published on: 2025-11-07 05:47:28  newser.com Fri, 07 Nov 2025 11:47:28 GMT
 Foghorn Therapeutics Eyes Growth With Eli Lilly Collaboration  Finimize Thu, 06 Nov 2025 21:24:21 GMT
 Foghorn Therapeutics CFO Kristian Humer Resigns  MSN Thu, 06 Nov 2025 07:49:35 GMT
 Foghorn Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 05:33:55 GMT
 foghorn therapeutics eyes growth with eli lilly collaboration  Finimize Wed, 05 Nov 2025 15:31:31 GMT
 FHTX Exceeds Revenue Expectations and Advances Cancer Therapy  GuruFocus Wed, 05 Nov 2025 14:53:38 GMT
 foghorn therapeutics reports q3 eps (25c), consensus (30c)  TipRanks Wed, 05 Nov 2025 12:39:07 GMT
 Foghorn Therapeutics CFO Kristian Humer Resigns  TipRanks Wed, 05 Nov 2025 12:33:48 GMT
 Foghorn Therapeutics Inc. SEC 10-Q Report  TradingView Wed, 05 Nov 2025 12:13:01 GMT
 Incyte aboard, SMARCA2 shift by Prelude enshrouds Foghorn  BioWorld MedTech Tue, 04 Nov 2025 15:00:00 GMT
 foghorn therapeutics eyes growth with eli lilly collaboration  Finimize Tue, 04 Nov 2025 03:41:46 GMT
 foghorn therapeutics eyes growth with eli lilly collaboration  Finimize Mon, 03 Nov 2025 21:41:46 GMT
 published on: 2025-11-03 02:03:18  newser.com Mon, 03 Nov 2025 08:03:18 GMT
 Foghorn Therapeutics to engage investors at oncology conferences  Traders Union Mon, 03 Nov 2025 08:00:00 GMT
 published on: 2025-11-03 01:08:21  newser.com Mon, 03 Nov 2025 07:08:21 GMT
 published on: 2025-11-02 14:15:30  newser.com Sun, 02 Nov 2025 19:15:30 GMT
 published on: 2025-11-02 02:35:38  newser.com Sun, 02 Nov 2025 07:35:38 GMT
 published on: 2025-11-01 05:22:36  newser.com Sat, 01 Nov 2025 10:22:36 GMT

Foghorn Therapeutics Inc
(NASDAQ:FHTX) 

FHTX stock logo

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug tar...

Founded: 2015
CEO: Adrian Gottschalk  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends